ArticleDemography2025
Variation in Black and White Life Expectancy Across State Policy Groups, 1990-2019: A Research Note.
Article in Demography, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
Abstract
This research note examines the U.S. policy landscape of longevity by documenting life expectancy trends between 1990 and 2019 among Black and White men and women across state policy contexts, grouped by policy liberalism trajectories over the last 60 years. I estimate age group and cause-of-death contributions to the growth of the liberal state life expectancy advantage, which culminated in 2018-2019 to between 2.5 and 3.8 years. Notably, by 2018-2019, Black life expectancy, particularly among women, in liberal policy environments had surpassed or equaled White life expectancy in certain conservative contexts. Although clear policy gradients emerge for White populations, Black life expectancy appears to be less patterned across policy environments, with advantage concentrated in the most liberal states. The growth of the liberal advantage was driven primarily by improvements at younger ages (<50) and in HIV/AIDs and homicides among Black, particularly male, populations; in late adulthood (50-74) and in cancers, circulatory diseases, and respiratory diseases among White populations; and at the oldest ages (75+) and in mental and nervous system disorders among women. Negative contributions of drug-related mortality, particularly among men, suggest that the drug epidemic undermined further growth of the liberal state advantage.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.